Literature DB >> 23709293

Chryseobacterium indologenes central nervous system infection in infancy: an emergent pathogen?

P Olbrich1, M Rivero-Garvía, M D Falcón-Neyra, J A Lepe, J M Cisneros, J Marquez-Rivas, O Neth.   

Abstract

The isolation of Chryseobacterium indologenes as a causative micro-organism in human diseases is rare. Risk factors for infections caused by this pathogen include very young and very old age, indwelling devices, immune suppression and recent use of broad-spectrum antibiotics. Most cases suffer from bacteraemia or nosocomial pneumonia, whilst infection of the central nervous system (CNS) is extremely rare. We present a term-born infant diagnosed prenatally with holoprosencephaly and obstructive hydrocephalus, requiring post-natal ventriculoperitoneal shunt insertion. At 6 weeks of age, he suffered from Escherichia coli meningitis, showing satisfactory clinical response with antimicrobial therapy. Aged 11 months, he suffered from hyper-drainage syndrome, resulting in the removal of the shunt system. He represented 11 days post-operatively, with low-grade fever, irritability and cerebrospinal fluid (CSF) leakage. C. indologenes from CSF was isolated and antimicrobial therapy with ceftazidime and trimethoprim-sulfamethoxazole for 3 weeks resulted in good clinical response. This is the first documented community-acquired CNS infection due to C. indologenes in an infant without concomitant indwelling device or previous antibiotic pressure.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23709293     DOI: 10.1007/s15010-013-0479-y

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  18 in total

1.  [Corneal abscess by Flavobacterium indologenes. A case report].

Authors:  O Doiz; M T Llorente; A Mateo; C Seral; C García; M C Rubio
Journal:  Enferm Infecc Microbiol Clin       Date:  1999-03       Impact factor: 1.731

2.  Recurrent bacteremia by Chryseobacterium indologenes in an oncology patient with a totally implanted intravascular device.

Authors:  E Nulens; B Bussels; A Bols; B Gordts; H W Van Landuyt
Journal:  Clin Microbiol Infect       Date:  2001-07       Impact factor: 8.067

3.  Chryseobacterium indologenes non-catheter-related bacteremia in a patient with a solid tumor.

Authors:  George B Christakis; Stavroula P Perlorentzou; Irene Chalkiopoulou; Athanasios Athanasiou; Nikolas J Legakis
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

4.  Flavobacterium indologenes bacteremia: clinical and microbiological characteristics.

Authors:  P R Hsueh; T R Hsiue; J J Wu; L J Teng; S W Ho; W C Hsieh; K T Luh
Journal:  Clin Infect Dis       Date:  1996-09       Impact factor: 9.079

5.  [Pneumonia from Flavobacterium indologenes (group II B) in an immunodepressed patient].

Authors:  F Marcos Sánchez; R Plaza Díaz; F Juárez Ucelay; A Durán Pérez-Navarro
Journal:  An Med Interna       Date:  1993-06

6.  High protease activity of Chryseobacterium indologenes isolates associated with invasive infection.

Authors:  H J Pan; L J Teng; Y C Chen; P R Hsueh; P C Yang; S W Ho; K T Luh
Journal:  J Microbiol Immunol Infect       Date:  2000-12       Impact factor: 4.399

7.  Postoperative Chryseobacterium indologenes bloodstream infection caused by contamination of distillate water.

Authors:  Mehmet Refik Bayraktar; Elif Aktas; Yasemin Ersoy; Aysegul Cicek; Riza Durmaz
Journal:  Infect Control Hosp Epidemiol       Date:  2007-02-07       Impact factor: 3.254

8.  Chryseobacterium indologenes bacteraemia in a diabetic child.

Authors:  Antonio Cascio; Giovanna Stassi; Gaetano B Costa; Giuseppe Crisafulli; Immacolata Rulli; Caterina Ruggeri; Chiara Iaria
Journal:  J Med Microbiol       Date:  2005-07       Impact factor: 2.472

9.  Ventricular cerebrospinal fluid concentrations of trimethoprim-sulphamethoxazole.

Authors:  E E Wang; C G Prober
Journal:  J Antimicrob Chemother       Date:  1983-04       Impact factor: 5.790

10.  Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997-2001).

Authors:  Jeffrey T Kirby; Helio S Sader; Timothy R Walsh; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

View more
  5 in total

1.  A Case of Healthcare Associated Pneumonia Caused by Chryseobacterium indologenes in an Immunocompetent Patient.

Authors:  Salih Atakan Nemli; Tuna Demirdal; Serap Ural
Journal:  Case Rep Infect Dis       Date:  2015-01-06

2.  Chryseobacterium indologenes Septicemia in an Infant.

Authors:  Turkan Aydin Teke; Fatma Nur Oz; Ozge Metin; Gulsum Iclal Bayhan; Zeynep Gökce Gayretli Aydin; Melek Oguz; Gonul Tanir
Journal:  Case Rep Infect Dis       Date:  2014-07-10

3.  Whole genome sequencing uncovers a novel IND-16 metallo-β-lactamase from an extensively drug-resistant Chryseobacterium indologenes strain J31.

Authors:  Shaoqiang Wu; Beiwen Zheng; Tingting Wang; Xiawei Jiang; Chunyan Feng; Ang Li; Huihui Dong
Journal:  Gut Pathog       Date:  2016-10-21       Impact factor: 4.181

4.  Ventilator-associated pneumonia caused by Chryseobacterium indologenes: a rare infant case and review of the literature.

Authors:  Serkan Atıcı; Zeynep Alp Ünkar; Kübra Erdem; Eda Kepenekli Kadayifci; Ayşe Karaaslan; Aslı Çınar Memişoğlu; Ahmet Soysal; Nurver Ülger Toprak; Güner Söyletir; Eren Özek; Mustafa Bakır
Journal:  Springerplus       Date:  2016-10-07

5.  Chryseobacterium indologenes, a possible emergent organism resistant to carbapenem antimicrobials after stem cell transplantation.

Authors:  Osamu Imataki; Makiko Uemura
Journal:  Clin Case Rep       Date:  2016-12-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.